A Safety and Efficacy Long-Term Follow-up Study of Adult Participants Treated With Gene Modified T Cells
NCT06798298
·
clinicaltrials.gov ↗
RECRUITING
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Long Term Safety Following GM T Cell Therapy
Interventions
GENETIC:
Non-interventional
Sponsor
Regeneron Pharmaceuticals